|Mortality (All-Cause)||Hospitalization (All-Cause)||MLwHF (Follow-Up)||HRQOL (All Scales) (Follow-Up)|
|No. of studies||26||20||14||21|
|Effect estimate (95% CI)||OR: 0.85 (0.71 to 1.01)||OR: 0.64 (0.44 to 0.93)||WMD: −7.24 (−11.84 to −2.63)||SMD: −0.48 (−0.73 to −0.24)|
|Peters or Egger test: p value||Peters: 0.162||Peters: 0.373||Egger: 0.798||Egger: 0.078|
HRQOL = Health-related quality of life; MLwHF = Minnesota Living with Heart Failure questionnaire; OR = odds ratio; SMD = standardized mean difference; other abbreviations as in Table 2.
↵∗ DerSimonian and Laird random effects method. Treatment or lower than 1.0 favors exercise intervention; negative SMD/WMD favors exercise intervention. Positive weighted (by inverse variance) changes in exercise capacity values favor the exercise rehabilitation group. Number of studies, effect estimates (95% CI), p value for significance of effect size, I2 statistic, and Peters or Egger test p value for small-study effect reported.